Health-Tech Startup Oncare Raises ₹27 Crore in Series A
Oncare, a health-technology startup, has raised ₹27 crore in a Series A funding round led by Sky Impact Capital. The investment reflects continued venture capital interest in technology-enabled models focused on service distribution and accessibility.
- Oncare operates on a "hospital-in-hospital" model, establishing and managing specialized oncology departments within existing mid-sized, non-branded hospitals. This capital-efficient approach avoids the high cost of building new facilities and is designed for rapid scaling. - The startup was founded in 2023 by Amar Sneh and Deepak Kumar, both of whom previously worked at the surgical care platform Pristyn Care. - A key part of Oncare's strategy is to make cancer treatment more affordable, claiming its chemotherapy prices are about 40% lower and surgeries are 30-40% cheaper than at large corporate hospitals. - The fresh capital is earmarked for expansion beyond its four current centers in Delhi-NCR, with plans to launch in Bangalore and several Tier 2 and Tier 3 cities, particularly in Uttar Pradesh, Bihar, and West Bengal, where there is a significant gap in accessible cancer care. - Since its inception, the company has interacted with approximately 30,000 patients, leading to 3,000 oncologist consultations and treatment for about 1,000 patients. - This Series A round included participation from other investors such as Huddle Ventures, Lotus Herbal Group, Steerx, and Tremis Capital. - Prior to this round, Oncare raised a $1 million seed round in October 2024, which was led by Huddle Ventures. - The company aims to address the lack of accessible, quality cancer care in India, a market projected to reach ₹43,000 crore by FY28.
